Coverage of the 17th IAAF World Championships #Doha2019 is brought to you by:
Jamaica’s rising sprint star Briana Williams has escaped with a public reprimand for a failed drug test at Jamaica Trials in June.
The decision was handed down today (26 Sept) by the Independent Anti-Doping Disciplinary Panel (IADP) panel, chaired by Kent Gammon and included Dr Marjorie Vassell and Ms Denise Forrest.
“Public reprimand and no period of ineligibility,” was the decision arrived at by the panel according to information reaching Trackalerts.com
Williams tested positive for the banned diuretic Hydrochlorothiazide (HCTZ) at the Jamaica Trials in June.
“The IADP is unanimously persuaded to the standard of proof on the evidence presented that the athlete, Miss Briana Williams, was in breach of article 2.1 of the 2015 Anti-Doping Rules as she had in her body a specified substance namely “Hydrochlorothiazide”.
“The IADP finds that the athlete has established no significant fault or negligence as she was given tablets by her guardian and had no intention to cheat in her In-Competition sprint event on 21st June 2019. The IADP was referred to article 10.5.1.1 of the Anti-Doping In Sport Rules and this is relied on in its findings.
“In the circumstances of this case, the athlete is reprimanded without any period of ineligibility.
“The IADP recommends that the athlete undergoes another education programme on Anti-Doping In Sports Rules as soon as JADCO carries out same.”
We want to hear from you! Join our lively discussion by leaving a comment below. You can also email us at email@example.com or WhatsApp your results, photos and videos to 876-893-4157